Refractory DLBCL: Challenges and Treatment
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference77 articles.
1. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002
2. Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large b-cell lymphoma: clinical outcomes of the phase III intergroup trial alliance/CALGB 50303;Bartlett;J Clin Oncol,2019
3. Randomized phase II study of R-CHOP with or without bortezomib in previously untreated patients with non-germinal center B-cell-like diffuse large B-Cell lymphoma;Leonard;J Clin Oncol,2017
4. ROBUST: a phase III study of lenalidomide plus R-CHOP versus placebo plus R-CHOP in previously untreated patients with ABC-type diffuse large B-cell lymphoma;Nowakowski;J Clin Oncol,2021
5. Addition of lenalidomide to R-CHOP improves outcomes in newly diagnosed diffuse large B-cell lymphoma in a randomized phase II US intergroup study ECOG-ACRIN E1412;Nowakowski;J Clin Oncol,2021
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Blinatumomab consolidation post–autologous stem cell transplantation in patients with diffuse large B-cell lymphoma;Blood Advances;2024-02-13
2. Development and Validation of a Novel Prognostic Nomogram for advanced Diffuse Large B-Cell Lymphoma;2023-10-28
3. The new world of RNA diagnostics and therapeutics;Journal of Experimental & Clinical Cancer Research;2023-07-29
4. Selinexor and Other Selective Inhibitors of Nuclear Export (SINEs)—A Novel Approach to Target Hematologic Malignancies and Solid Tumors;Drugs and Drug Candidates;2023-05-31
5. Does standard pharmacotherapy still have a major role in the treatment of aggressive B-cell malignancies?;Expert Opinion on Pharmacotherapy;2022-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3